Drugs Directorate guidelines: H42-2/1E
Developed by the Drugs Directorate of the Health Protection Branch to guide drug manufacturers through the various levels of the approval process. Amendment service supplied for each section by Standing Order.
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.514728&sl=0
| Department/Agency |
|
|---|---|
| Title | Drugs Directorate guidelines |
| Publication type | Series - Browse issue records |
| Language | [English] |
| Other language editions | [French], Bilingual-[English | French], Bilingual-[English | French] |
| Format | Physical text |
| Other formats | Digital text-[English] |
| Publishing information |
|
| Binding | Loose-leaf |
| Catalogue number |
|
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.Page details
- Date modified: